Benzinga's Top Pre-Market Gainers

Loading...
Loading...
Aeterna Zentaris
AEZS
added 4.15% to $2.26 in the pre-market session. Aeterna Zentaris granted Special Protocol Assessment by the U.S. Food and Drug Administration for Phase 3 registration trial in endometrial cancer with AEZS-108. Arena Pharmaceuticals
ARNA
moved up 1.71% to $8.94 in the pre-market session. Arena Pharmaceuticals shares have jumped 370.05% over the past 52 weeks, while the S&P 500 index has gained 12.76% in the same period. LSI
LSI
soared 1.61% to $7.10 in the pre-market trading. Analysts at Wunderlich initiated coverage on shares of LSI with a “buy” rating. Marvell Technology Group
MRVL
surged 1.54% to $7.25 in the pre-market session. Analysts at Wunderlich initiated coverage on shares of Marvell with a “hold” rating.
Posted In: NewsPre-Market OutlookMarketsMoversInformation TechnologySemiconductorsTop Pre-Market Gainers
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...